NCT07040397 Electronic Approach to the Human Massage Therapist
| NCT ID | NCT07040397 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Lower Back Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2026-01-30 |
| Primary Completion | 2026-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2026-01-30 with a primary completion date of 2026-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to gather information about patient experience receiving a massage through a robotic EMMA (Expert Manipulative Massage Automation) compared to receiving a massage from a massage therapist.
Eligibility Criteria
Inclusion Criteria: * be 18 years of age or older. * report a primary pain point in the lower back. * Pain intensity reported at baseline * Women of childbearing potential who self-report not being pregnant and agree to employ an effective method of birth control (surgical sterilization or oral contraceptives, barrier method with spermicides, intrauterine device, etc.) during the study period * be able to participate fully in all aspects of the study. * have understood and signed study informed consent. Exclusion Criteria: * Pregnancy or breastfeeding * Patients with the inability to stay in a prone position * Patients with bleeding disorders * Patients with allergies and/or local skin affectations * have used pain medications or participated in a pain treatment within three days of study enrollment. * have an implanted device (including a lap band) in the targeted area of massage therapy. * have used an investigational drug within 30 days of study enrollment. * have a history of any major cardiovascular events including heart valve disease, ongoing angina, cardiac arrhythmias, congestive heart failure, acute coronary syndrome, stroke, transient ischemic attack, or peripheral vascular disease. * have clinically significant acute or chronic progressive or unstable neurologic, hepatic, renal, cardiovascular, lymphatic, respiratory, metabolic disease (such as uncontrolled diabetes type 2) active cancer, actively receiving treatment for cancer or within 1 year of cancer remission. * surgical intervention for pain within 1 month prior to enrollment. * active infection, wound or other external trauma to the areas to be treated with massage therapy. * have a known history of any condition or factor judged by the investigator to preclude participation in the study or which might hinder adherence.
Contact & Investigator
Michael Mueller
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT07040397 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Lower Back Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07040397 currently recruiting?
Yes, NCT07040397 is actively recruiting participants. Visit ClinicalTrials.gov or contact Mayo Clinic to inquire about joining.
Where is the NCT07040397 trial being conducted?
This trial is being conducted at Rochester, United States.
Who is sponsoring the NCT07040397 clinical trial?
NCT07040397 is sponsored by Mayo Clinic. The principal investigator is Michael Mueller at Mayo Clinic. The trial plans to enroll 40 participants.